Centessa Pharmaceuticals (CNTA) Leases (2023 - 2025)
Centessa Pharmaceuticals (CNTA) has disclosed Leases for 3 consecutive years, with $10.0 million as the latest value for Q4 2025.
- Quarterly Leases fell 8.77% to $10.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2025, down 8.77% year-over-year, with the annual reading at $10.0 million for FY2025, 8.77% down from the prior year.
- Leases for Q4 2025 was $10.0 million at Centessa Pharmaceuticals, down from $10.3 million in the prior quarter.
- The five-year high for Leases was $12.3 million in Q2 2023, with the low at $10.0 million in Q4 2025.
- Average Leases over 3 years is $11.3 million, with a median of $11.4 million recorded in 2024.
- The sharpest move saw Leases decreased 4.65% in 2024, then decreased 8.77% in 2025.
- Over 3 years, Leases stood at $11.9 million in 2023, then dropped by 7.56% to $11.0 million in 2024, then fell by 8.77% to $10.0 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $10.0 million, $10.3 million, and $10.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.